Zenotech Laboratories Ltd

As of 06-Nov, Zenotech Laboratories Ltd's stock price is Rs 50.33, down 4.95%, and has significantly underperformed compared to its sector and the broader market. The stock is in a bearish trend, trading below key moving averages, and has declined 41.34% over the past year.

Zenotech Laboratories' latest Q1 FY26 results are concerning, showing a 2.81% year-on-year decline in net sales and a significant drop in operating margins to 28.47%. The company faces challenges with rising costs and reduced profitability, reflected in a 23.26% decrease in net profit.

Zenotech Lab has experienced declining net sales and increasing losses from 2008 to 2010, with net sales dropping from 8.24 Cr to 6.57 Cr. However, there are signs of improvement in cash management, as cash and cash equivalents rose significantly during the same period.

As of 30-Oct, Zenotech Laboratories Ltd is currently priced at 53.00, reflecting a recent price increase despite a negative year-to-date performance of -26.34%. While it has gained 9.05% over the last week, its longer-term performance remains weak compared to the broader market.

As of 17-Oct, Zenotech Laboratories Ltd's stock price is Rs 50.10, down 0.61%, and it has underperformed against the Sensex, which has gained 1.76% over the past week. The stock is trading below key moving averages and is close to its 52-week low, indicating weak investor participation and broader market challenges.

As of 24-Sep, Zenotech Laboratories Ltd's stock price is at 53.00, reflecting a decline of 1.3% and a significant drop in delivery volume by 79.95%. Despite a recent 5.45% gain over the past week, the stock has a year-to-date decline of 26.34% and a one-year drop of 45.94%, indicating ongoing long-term struggles.

As of 23-Sep, Zenotech Laboratories Ltd's stock price is at 53.80, with a recent short-term gain of 2.4% but a significant year-to-date decline of 25.23%. Despite a low Debt to EBITDA ratio indicating some financial stability, the stock is perceived as a strong sell due to poor long-term performance and declining investor interest.

As of 22-Sep, Zenotech Laboratories Ltd is priced at 53.12, having increased by 1.1% today, but it has underperformed with a 4.37% decline over the past week and 26.17% year-to-date. The stock is trading below key moving averages and has seen a significant drop in investor participation, indicating a negative sentiment compared to the broader market.

As of 19-Sep, Zenotech Laboratories Ltd's stock price is declining at 52.32, down 1.12%, and has underperformed its sector significantly. The company faces poor financial results, a substantial year-to-date decline, and decreased investor participation, contributing to its negative performance relative to the broader market.

As of 18-Sep, Zenotech Laboratories Ltd is currently priced at Rs 52.91, reflecting a short-term increase despite a negative performance over the past week and month. The stock has underperformed significantly compared to the benchmark Sensex over the past year, indicating a weak long-term outlook.